{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T22:15:08Z","timestamp":1774736108724,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate the impact of baseline vitreomacular interface status on treatment outcomes in patients treated with three different anti\u2013vascular endothelial growth factors for diabetic macular edema.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Post hoc analysis from patients enrolled in the DRCR.net Protocol T study. Optical coherence tomography images were analyzed at baseline and at the end of follow-up to identify the presence of complete vitreomacular adhesion, partial vitreomacular adhesion, vitreomacular traction syndrome, and complete posterior vitreous detachment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Six hundred and twenty-nine eyes were eligible for the study based on the study criteria. Complete adhesion eyes gained on average +3.7 more ETDRS letters compared with the complete posterior vitreous detachment group at the end of the 12 months follow-up (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Baseline vitreomacular interface status had no significant influence on central subfield thickness at 12 months (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.144). There was no difference between the treatment arms based on effect of baseline vitreomacular interface status on best-corrected visual acuity gain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study provides evidence that vitreomacular interface status affects functional outcomes in diabetic macular edema patients treated with anti\u2013vascular endothelial growth factor injections. The presence of complete or partial vitreomacular adhesion at baseline may be associated with a larger treatment benefit than those with complete posterior vitreous detachment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003594","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T20:00:10Z","timestamp":1660420810000},"page":"2066-2074","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["THE IMPACT OF THE VITREOMACULAR INTERFACE ON FUNCTIONAL AND ANATOMICAL OUTCOMES IN DIABETIC MACULAR EDEMA TREATED WITH THREE DIFFERENT ANTI-VEGF AGENTS"],"prefix":"10.1097","volume":"42","author":[{"given":"Georgios","family":"Mylonas","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal Haj","family":"Najeeb","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Goldbach","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor G.","family":"Deak","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Michl","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Brugger","sequence":"additional","affiliation":[{"name":"Center for Medical Statistics, Informatics and Intelligent Systems, Section for Medical Statistics, Medical University of Vienna, Vienna, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8940-8130","authenticated-orcid":false,"given":"Bianca S.","family":"Gerendas","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","year":"2015","journal-title":"Eye Vis (Lond)"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2015.09.032","article-title":"Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes READ-3 study group","volume":"123","author":"Sadiq","year":"2016","journal-title":"Ophthalmology"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomizedtrials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"1064e1077","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Diabetic Retinopathy Clinical Research Network. Randomizedtrial evaluating ranibizumab plus prompt or deferred laser ortriamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmology"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10384-013-0302-4","article-title":"Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion","volume":"58","author":"Terao","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/IAE.0b013e3182278b80","article-title":"Influence of vitreomacular adhesion on the development of exudative age-related macular degeneration: 4-year results of a longitudinal study","volume":"32","author":"Waldstein","year":"2012","journal-title":"Retina Phila PA"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajo.2014.04.028","article-title":"Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration","volume":"158","author":"Waldstein","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.ophtha.2013.05.032","article-title":"Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration","volume":"120","author":"Mayr-Sponer","year":"2013","journal-title":"Ophthalmology"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Wells","year":"2015","journal-title":"N Engl J Med"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00417-004-0980-1","article-title":"Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease","volume":"242","author":"Sebag","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1167\/iovs.13-13054","article-title":"Intraocular pharmacokinetics of ranibizumab in vitrectomized versus nonvitrectomized eyes","volume":"55","author":"Ahn","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1038\/s41598-017-02971-y","article-title":"Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learning","volume":"7","author":"Waldstein","year":"2017","journal-title":"Sci Rep"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajo.2008.04.027","article-title":"The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results","volume":"146","author":"Mojana","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2009.01.014","article-title":"Vitreomacular adhesion in active and end-stage age-related macular degeneration","volume":"148","author":"Robison","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s003470050054","article-title":"Incidence of posterior vitreous detachment in eyes with and without age-related macular degeneration: an ultrasonic study","volume":"93","author":"Weber-Krause","year":"1996","journal-title":"Ophthalmologe"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ajo.2008.10.003","article-title":"Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study","volume":"147","author":"Lee","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bjophthalmol-2019-314661","article-title":"Effect of posterior vitreous detachment on treat-and-extend versus monthly ranibizumab for neovascular age-related macular degeneration","volume":"104","author":"Waldstein","year":"2020","journal-title":"Br J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:03:24Z","timestamp":1749319404000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003594"}},"subtitle":["Post Hoc Analysis of The Protocol T Study"],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003594","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"2022-04-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}